The Effect of Synching Prescription Refills on Adherence
A Randomized Controlled Trial to Test a Synchronized Prescription Refill Program to Improve Medication Adherence
1 other identifier
interventional
691
1 country
1
Brief Summary
To determine the effect of synchronizing a patient's prescription refill schedule on medication adherence. The targeted population is Humana members who are currently taking 2 or more Stars medications (hypertension, hypercholesterolemia, diabetes) and are current customers of RightSource. Participants will be randomized to one of two groups. Group one will be usual care and group two will be the Rx synchronization group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Sep 2013
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedFirst Posted
Study publicly available on registry
September 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedDecember 22, 2015
December 1, 2015
2.2 years
August 29, 2013
December 21, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Medication adherence to each of the chronic medications as measured by the proportion of days covered (PDC) measure
6 months and 12 months
Secondary Outcomes (1)
Secondary outcomes will be continuous gaps (e.g. 15, 30, or 60 days) in medication use.
6 and 12 months
Study Arms (2)
Refill synch
EXPERIMENTALParticipants in this group will have their medication refill schedule synchronized.
Control
NO INTERVENTIONParticipants in this arm will receive usual care
Interventions
Eligibility Criteria
You may qualify if:
- Humana members who are currently taking 2 or more Stars medications (hypertension, hypercholesterolemia, diabetes) and are current customers of RightSource.
You may not qualify if:
- under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Humana, Inc
Louisville, Kentucky, 40202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jalpa Doshi, PhD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2013
First Posted
September 4, 2013
Study Start
September 1, 2013
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
December 22, 2015
Record last verified: 2015-12